Trial | Studied treatment | Control treatment | patients | ROB | Result | NCT |
---|
|
|
DEFINE, 2010 | anacetrapib | placebo | | Exploratory | Negative | NCT00685776 |
REALIZE, 2015 | anacetrapib | placebo | | | Negative | NCT01524289 |
|
BECAIT, 1996 | bezafibrate | placebo | secondary prevention | Exploratory | Suggesting | |
SENDCAP, 1998 | bezafibrate | placebo | | Exploratory | Suggesting | |
BIP, 2000 | bezafibrate | placebo | secondary prevention | Low risk of bias | Negative | |
LEADER, 2002 | bezafibrate | placebo | | Low risk of bias | Negative | |
|
Harrold, 1969 | clofibrate | placebo | | Low risk of bias | - | |
Scottish, 1971 | clofibrate | placebo | | Low risk of bias | Negative | |
Newcastle, 1971 | clofibrate | placebo | | Low risk of bias | Suggesting | |
Begg, 1971 | clofibrate | placebo | secondary prevention | Exploratory | Negative | |
Acheson, 1972 | clofibrate | placebo | secondary prevention | Exploratory | - | |
VA Neurology Section, 1974 | clofibrate | placebo | | Low risk of bias | - | |
Cullen, 1974 | clofibrate | placebo | | Low risk of bias | - | |
CDP Clofibrate, 1975 | clofibrate | placebo | | Low risk of bias | Suggesting | |
WHO clofibrate, 1978 | clofibrate | placebo | | Low risk of bias | Suggesting | |
Hanefeld, 1991 | clofibrate | placebo | | Low risk of bias | Negative | |
|
Emmerich, 2009 | etofibrate | placebo | diabetic | Exploratory | - | |
|
DAIS, 2001 | fenofibrate | placebo | diabetic | Exploratory | Negative | |
FIELD, 2005 | fenofibrate | placebo | diabetic | Exploratory | Suggesting | ISRCTN64783481 |
ACCORD lipid, 2010 | fenofibrate | placebo (on top simvastatine) | diabetic patients | Low risk of bias | Negative | NCT00000620 |
|
Helsinki (HHS), 1987 | gemfibrozil | placebo | | Low risk of bias | Suggesting | |
HHS (Frick)(secondary prev subgroup), 1993 | gemfibrozil | placebo | | Exploratory | Negative | |
LOCAT, 1997 | gemfibrozil | placebo | | Exploratory | Negative | |
VA-HIT, 1999 | gemfibrozil | placebo | | Low risk of bias | Suggesting | NCT00283335 |
|
HPS 2-Thrive | niacin | placebo (on top statin) | | Low risk of bias | Negative | NCT00461630 |
VA drugs, 1968 | niacin | control | | Low risk of bias | Negative | |
CDP niacin, 1975 | niacin | placebo | | Low risk of bias | Suggesting | |
HATS, 2001 | niacin | placebo (on top statin) | | Risk of bias | Negative | |
ARBITER 6-HALTS (niacin vs ezetimibe), 2009 | niacin | ezetimibe | | Exploratory | Suggesting | NCT00397657 |
Oxford Niaspan Study, 2009 | niacin | placebo (on top statin) | | Exploratory | - | NCT00232531 |
ARBITER 2, 2009 | niacin | placebo (on top statin) | | Exploratory | Negative | |
AIM-HIGH, 2011 | niacin | placebo (on top statin) | | Low risk of bias | Negative | NCT00120289 |
|
RADIANCE 1, 2007 | torcetrapib | placebo | | Exploratory | Negative | NCT00136981 |
ILLUMINATE, 2007 | torcetrapib | placebo | | | Negative | NCT00134264 |
RADIANCE 2, 2007 | torcetrapib | placebo | | Exploratory | - | |
ILLUSTRATE, 2007 | torcetrapib | placebo | | Exploratory | Negative | NCT00134173 |